Collectively, these findings demonstrated that butyrate was the key actuator through which pectin could modulate the efficacy of anti-PD-1 mAb in the tumor-bearing mice humanized with gut microbiota from CRC patients. The gene discussed is PDCD1; the disease is neoplasm.